Immunocore Holdings plc (IMCR) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $1.73B and a free-cash-flow yield of -0.9%. Over the most recent reported fiscal year, revenue grew 28.9% and free cash flow per share fell 171.6%.